Medicine and Dentistry
Patient
100%
Multiple Sclerosis
62%
Therapeutic Procedure
59%
Systematic Review
48%
Cerebral Hemorrhage
43%
Alzheimer's Disease
39%
Diagnosis
33%
Dementia
30%
Apoplexy
30%
Amyotrophic Lateral Sclerosis
29%
Symptom
29%
Association
27%
Degenerative Motor System Disorder
24%
Brain
22%
Adult
22%
Analysis
21%
Cognition
20%
Neurologic Disease
20%
Magnetic Resonance Imaging
20%
Inpatient
20%
Randomized Controlled Trial
19%
Remyelination
19%
Evaluation Study
19%
Meta-Analysis
18%
Consensus
18%
Lesion
18%
Cognitive Defect
17%
Assessment
17%
Diagnostics
16%
Drug
15%
Chemotherapeutic Agent
15%
Parkinson's Disease
15%
Induced Pluripotent Stem Cell
15%
Age
15%
Follow up
15%
Neurology
14%
Health
14%
Amaurosis
13%
Stereotypic Movement Disorder
13%
Cells
13%
Biological Marker
13%
Oligodendrocyte
13%
Neurodegeneration
12%
Hospital
12%
Degenerative Disease
11%
Nervous System Disorder
11%
Clinical Trial
11%
Incidence
11%
Neuroprotective Agent
11%
Screening
10%
Placebo
10%
Functional Disease
10%
Syndrome
10%
Arm
10%
Antithrombotic
10%
Cohort Analysis
10%
Cavernous Hemangioma
10%
Combination Therapy
9%
Epileptic Seizure
9%
Pain
8%
Cerebral Arteriovenous Malformation
8%
Myelination
8%
Central Nervous System
8%
Prevalence
7%
Cohort Effect
7%
Neuroimaging
7%
White Matter Lesion
7%
Death
7%
Cerebrovascular Disease
7%
Apathy
7%
Neuron
6%
Observational Study
6%
Quality of Life
6%
Prognosis
6%
Phenotype
6%
Pathology
6%
Demyelination
6%
Disease Exacerbation
6%
White Matter
6%
Examination
6%
Physiotherapy
6%
Regulatory Mechanism
6%
Patient Health Questionnaire 9
6%
Measurement
5%
Surgery
5%
Enalapril Maleate
5%
Fatigue
5%
Oligodendrocyte Precursor Cell
5%
Stem Cell
5%
Clinical Assessment
5%
Behavioral Change
5%
In Vitro
5%
Optical Coherence Tomography
5%
Accuracy
5%
Gray Matter
5%
Precursor
5%
Retinal Imaging
5%
Conservative Treatment
5%
Subarachnoid Hemorrhage
5%
Astrocyte
5%
Neuroscience
Amyotrophic Lateral Sclerosis
62%
Multiple Sclerosis
54%
Parkinson's Disease
45%
Intracerebral Hemorrhage
40%
Alzheimer's Disease
40%
Cognitive Disorders
37%
Meta-Analysis
32%
Dementia
31%
Neurodegenerative Disorder
28%
Stroke
27%
Neuron
26%
Brain
25%
Oligodendrocyte
25%
Motor Neurone Disease
21%
Neurodegeneration
20%
Cognition
19%
White Matter
16%
Mild Cognitive Impairment
15%
Neuroprotective Agent
14%
Anxiety
13%
Memory
13%
Placebo
12%
Gene
11%
Myelin
11%
Secondary Progressive Multiple Sclerosis
10%
Phenotype
10%
Remyelinization
10%
Nervous System Disorder
10%
Astrocyte
9%
Relapsing Remitting Multiple Sclerosis
9%
Frontotemporal Dementia
9%
Myelinogenesis
8%
In Vivo
8%
Executive Functions
8%
Magnetic Resonance Imaging
8%
Axon
8%
Central Nervous System
8%
Randomized Controlled Trial
7%
Magnetic Resonance Imaging
7%
Hematoma
6%
Behavior (Neuroscience)
6%
Motor Neuron
6%
Movement Disorder
6%
In Vitro
6%
Neural Stem Cell
6%
Riluzole
6%
Depression
6%
Fluoxetine
6%
Nerve Fiber Degeneration
6%
Sleep
6%
Amiloride
6%
Anticoagulant
6%
Cerebrovascular Disease
6%
Predictor
5%
Microglia
5%
Dependent Personality Disorder
5%
Cerebral Amyloid Angiopathy
5%
Tau Protein
5%
Behavior Change
5%
Cognitive Function
5%
Nursing and Health Professions
Patient
33%
Alzheimer Disease
21%
Dementia
18%
Parkinson Disease
15%
Diseases
15%
Motor Neuron Disease
13%
Symptom
12%
Diagnosis
11%
Amyotrophic Lateral Sclerosis
11%
Evaluation Study
10%
Quality of Life
10%
Multiple Sclerosis
10%
Control
10%
Cognitive Defect
9%
Mild Cognitive Impairment
8%
Meta Analysis
8%
Systematic Review
8%
Follow up
8%
Time
8%
Practice Guideline
7%
Consensus
7%
Brain Hemorrhage
7%
Reliability
6%
Analysis
6%
Clinician
6%
Depression
6%
Validity
6%
Self Care
6%
Researcher
6%
Imaging
6%
Standard
6%
Motor Dysfunction
6%
Screening
5%
Procedures
5%
Placebo
5%